Deepu Madduri Selected Research

Interferons

1/2022

A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deepu Madduri Research Topics

Disease

36	Multiple Myeloma 11/2023 - 11/2017
8	Neoplasms (Cancer) 06/2023 - 01/2019
5	COVID-19 01/2022 - 05/2020
4	Cytokine Release Syndrome 12/2023 - 01/2019
3	Hypoxia (Hypoxemia) 01/2022 - 05/2020
3	Inflammation (Inflammations) 01/2022 - 05/2020
3	Agammaglobulinemia (Hypogammaglobulinemia) 01/2021 - 01/2020
2	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2023 - 01/2023
2	cell-associated neurotoxicity 12/2023 - 01/2023
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 01/2023
2	Infections 09/2021 - 01/2021
2	Hypertension (High Blood Pressure) 11/2020 - 06/2020
1	Plasmablastic Lymphoma 01/2023
1	Pneumonia (Pneumonitis) 01/2022
1	Parkinsonian Disorders (Parkinsonism) 12/2021
1	Nausea 12/2021
1	Fatigue 12/2021
1	Thrombocytopenia (Thrombopenia) 12/2021
1	Movement Disorders (Movement Disorder) 12/2021
1	Cytopenia 09/2021
1	Bites and Stings (Sting) 01/2021
1	Frailty 01/2020
1	Smoldering Multiple Myeloma 01/2018
1	Heart Arrest (Cardiac Arrest) 06/2008
1	Costello Syndrome 06/2008

Drug/Important Bio-Agent (IBA)

15	Chimeric Antigen ReceptorsIBA 11/2023 - 01/2019
9	B-Cell Maturation AntigenIBA 01/2023 - 01/2019
6	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 11/2023 - 01/2019
6	Proteasome InhibitorsIBA 11/2023 - 01/2020
5	Monoclonal AntibodiesIBA 11/2023 - 01/2019
4	idecabtagene vicleucelIBA 01/2023 - 01/2019
4	selinexorIBA 01/2022 - 01/2020
3	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021 - 01/2020
3	daratumumabIBA 01/2021 - 01/2018
3	carfilzomibIBA 01/2021 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2018
3	CytokinesIBA 10/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 06/2023 - 01/2020
2	AntigensIBA 01/2023 - 01/2020
2	Single-Domain AntibodiesIBA 12/2022 - 01/2021
2	Immunoglobulin G (IgG)IBA 11/2020 - 06/2020
2	Melphalan (Alkeran)FDA LinkGeneric 11/2020 - 06/2020
2	Interleukin-8 (Interleukin 8)IBA 10/2020 - 05/2020
2	Interleukin-6 (Interleukin 6)IBA 10/2020 - 05/2020
2	Ferritins (Ferritin)IBA 06/2020 - 01/2020
2	fibrin fragment D (D-dimer)IBA 06/2020 - 01/2020
1	InterferonsIBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	gimsilumabIBA 01/2022
1	7- chloro- 8- hydroxy- 1- (3'- iodophenyl)- 3- methyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepine (TISCH)IBA 12/2021
1	Bortezomib (Velcade)FDA Link 12/2021
1	Bispecific AntibodiesIBA 09/2021
1	isatuximabIBA 01/2021
1	belantamab mafodotinIBA 01/2021
1	insulin receptor-related receptor (IRR)IBA 01/2021
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	InterleukinsIBA 10/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020
1	VaccinesIBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Protein Subunit VaccinesIBA 01/2020
1	pomalidomideIBA 01/2020
1	Immunomodulating AgentsIBA 01/2020
1	Anesthetics (Anesthetic Agents)IBA 06/2008

Therapy/Procedure

23	Therapeutics 12/2023 - 11/2017
3	Immunotherapy 01/2020 - 01/2019
2	Artificial Respiration (Mechanical Ventilation) 11/2020 - 06/2020
1	Blood Component Removal (Apheresis) 12/2023
1	Drug Therapy (Chemotherapy) 06/2023
1	Aftercare (After-Treatment) 06/2023
1	Stem Cell Transplantation 10/2020
1	Precision Medicine 01/2018
1	Transplantation 01/2018
1	Anesthesia 06/2008